Predictive Oncology Inc (POAI)

[ash111]

I would say a very good start for a company just receiced CE mark. You must not follow biotech all that closely., biotech on phase2/3 or before markerting approval don't have sells at all. more important w/these is Cash on hand and Cash burn rate. since company completed financing recently and has about $5.2m cash w/tiny debt and solid balance sheet, these factors provide solid start for a $8m cap company, pretty reasonable. when company dosn't hold debt, future net profit margin surging, no need to dilute, and no fear from rate hike. BTW. Revenue Increased by 81.5% for the first quarter of 2017.

just a few examples: ARCX (Phase 3), only 3m revenues vs $100m market cap, AVEO (Phase 3), $2.5m revenues vs $245m market cap.
we can expect a revenues boost w/ high net future profit margin:

From past week pr:

"Skyline has received inquiries from many hospitals that are interested in purchasing STREAMWAY Systems for their operating and procedure rooms, and invariably the topic of installation is raised".

"Our most recent achievement was receiving notification that we can affix the CE mark to the STREAMWAY® System, thereby allowing for us to market and sell the STREAMWAY in 32 European countries. With this important and hard-earned milestone behind us, we are now actively engaged in the process of assembling the proper distribution network. We are specifically targeting markets we can penetrate early and more easily. We expect to launch the STREAMWAY System and record our first European sale by the end of the year. Our team anticipates a full European rollout to be complete by early 2018".

We are speaking with several high-quality distribution partners with priority access into Veterans Affairs hospitals and other federal facilities. Our new consultant has 60 veteran employees around the world, including 42 in the U.S. They are advocating for our product in the U.S. government market and are working with Service Disabled Veteran Owned Small Business (SDVOSB) distributors that will resell our product.

can easily sees at least $50m market cap till Year-end imo.